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ABSTRACT 
 
An in vivo study of the activity of scopoletin isolated from noni fruit (Morinda citrifolia L.) on the level 
of interleukin-4 (IL-4) in type I hypersensitive male Swiss-Webster mice has been carried out. Scopoletin was 
isolated from dried noni powder by soxhletation method using dichloromethane, separated by column 
chromatography using silica gel as stationary phase and n-hexane-ethyl acetate (1:4) as mobile phase, then 
purified by column chromatography using Sephadex LH20 as stationary phase and methanol as mobile phase. 
Type I hypersensitive male mice were obtained by ovalbumin sensitization. Animal model were divided into 5 
groups: negative control group, positive control group, and scopoletin-treated group (1; 3; and 10 mg/kg). The 
results showed that scopoletin at doses of 1, 3 and 10 mg/kg decreased the level of IL-4 of type I 
hypersensitive mice significantly (p <0.01). The scopoletin at the dose of 10 mg/kg decreased the serum level 
of IL-4 to the normal level. 
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INTRODUCTION 
 
Type I hypersensitivity reaction is an abnormal immunologic reaction to an antigen in those who had 
previously been sensitized to the antigen, and occurs when IgE antibody is produced in response to antigens or 
allergens [1]. Bronchial asthma, allergic rhinitis, and atopic dermatitis are diseases related to type I 
hypersensitivity reactions. Type I hypersensitivity reactions can be provoked by allergens such as pollen, food, 
cold, dry air, dust, smoke, animals, drugs, fungi, viruses, chemicals or industrial output and emotional stress 
[2,3]. 
 
The entry of allergens into the body causes an immune response with subsequent formation of IgE 
that binds to the surface of mast cells and basophils cells [4,5]. The exposure process begins with phagocytosis 
of allergen by macrophages. Macrophages destroy allergens into several peptide fragments and bind into MHC 
class II molecules and carried to the cell surface of macrophages and presented to the cells Tho (naive helper). 
Macrophages release several cytokines such as IL-1 (interleukin) and TNF- (- factor necrosis cancer). The Th 
cells that receive signals from macrophages undergo cell differentiation and proliferation into Th1 and Th2 
cells. Allergens are also phagocyted by mastocyte and basophil cells, then these cells will release IL-4. 
Increased level of IL-4 causes the proliferation and differentiation of Th0 cells are limited to become Th2 cells 
only. The Th2 cells release several cytokines such as IL-4, IL-5, IL-10, and IL-13 [6]. IL-4 exhibits a direct effect 
on B lymphocytes that subsequently differentiate and proliferate into plasma, which in turn produces IgE [7,8]. 
One of the plants that has been used to treat allergies is noni fruit (Morinda citrifolia L.) [9]. Besides 
antiallergic, noni fruit has also been used as antibacterial, antiviral, anticancer, antihelmintic, analgesic, 
hypotensive, anti-inflammatory and immunostimulant, to reduce the growth of tumor cells, and anti-ulcer [10-
12]. Nowadays, the use of herbs in medication is very common among the society. This should be supported by 
scientific research to prove the efficacy [13].  
 
 Previous studies showed that the extract of noni fruit could inhibit active cutaneous anaphylaxis 
reaction in mice induced by white albumin [14] and showed in-vitro inhibition of sensitized mastocyte 
degranulation induced by albumin [15]. Topical application of the extract could also suppress the inflammatory 
reaction [16]. The extract could also increase antibody titers in male mice induced by sheep red blood cells and 
could increase the number of lymphocytes, neutrophils and eusinofil stem cells [17]. 
 
 One of the active compound in the ethanol extract of noni fruit is scopoletin. Dried powder noni fruit 
contains not less than 0.02% of scopoletin [18]. Hyung et. al. has reported that scopoletin can inhibit 
mastocyte degranulation in mice; inhibit the production of PGE2 (prostaglandin E2), TNF-α, IL-1β, IL-6 and 
suppress COX-2 [19]. Scopoletin is also reported to decrease the level of IgE in type I hypersensitive mice [20]. 
The present study aimed to observe the effect of scopoletin isolated from noni fruit on the level of IL-4 in the 
type I hypersensitive male mice. 
 
MATERIALS AND METHOD 
 
Materials 
 
Paper filter, soxhlet extraction apparatus, rotary evaporator, chromatography columns, vials, TLC 
plates and backings, desiccator, Pasteur pipette, syringe, measuring cups, animal scales, spatel, needle oral, 
analytical scales, containers (bottle), mortar and stamfer, surgical scissors, 365 nm UV lamp, centrifuge, 
centrifuge tubes, UV-Vis spectrophotometer 1601 (Pharmaspec 1700), IR spectrophotometer (Perkin Elmer 
735) and BIO-RAD spectrophotometer. 
 
The material used were: the meat of noni fruit that has been dried and ground, dichloromethane 
(DCM), hexane, ethyl acetate, methanol, distilled water, physiological saline, Na CMC, scopoletin comparator 
(Exrtasynthese, Lot 10,041,510), distilled water, HCl (hydrochloric acid) 12N, ovalbumin (No. Brands. 
Lot.20HO763 A-5253) and mouse IL-4 kit Platinum ELISA (eBioscience, No. BMS613. 887 944). 
 
Isolation of scopoletin from noni fruit  
 
The dried powder of noni fruit underwent soxhlet extraction by using dichloromethane as the solvent. 
The extract was evaporated in vacuo to obtain thick extract. The eluate was collected with vials and the 
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isolated scopoletin was monitored by thin-layer chromatography (TLC) with a light stain apparition ultra violet 
(UV) at a wavelength of 365 nm. The scopoletin was detected in the vial 6 through 12. The obtained spot was 
still tailing which indicated other compounds left. The scopoletin in those seven vials were combined and 
dried. To purify the obtained scopoletin, a column chromatography was employed using Sephadex LH20 as 
stationary phase and methanol as mobile phase. Scopoletin pure compound was analyzed by UV and IR 
spectroscopy. 
 
Animals 
 
Healthy male Swiss-Webster mice weighing 20-25 g were injected with ovalbumin 5 mg/20g 
intraperitoneally. Ovalbumin was injected again at the third day in the same dose subcutaneously. Animals 
were declared as sensitive if redness arisen at the site of injections in the seventh day. 
 
The mice were divided into group I: normal animals; group II: type I hypersensitive mice given only 
physiological NaCl solution; group III, IV and V: type I hypersensitive mice given 1, 3, and 10 mg/kg of 
scolopeletin, respectively. The scopoletin was given immediately when redness arisen at the site of injection. 
 
Determination of interleukin-4 
 
After 24 hours of scopoletin administration, blood was taken by guillotine method. The blood was 
centrifuged 30 minutes later to obtain the serum. IL-4 level was determined by ELISA method. 
 
RESULTS AND DISCUSSION 
 
The scopoletin isolated from noni fruit was obtained 0.01%. According to Indonesian Herbal 
Pharmacopoeia I, 2008, noni fruit symplicia (dried powder) contains scopoletin compound not less than 0.02%. 
This shows that the present scopoletin extraction was not complete yet, hence the scopoletin compound 
obtained relatively fewer. 
 
TLC examination of the scopoletin isolated from noni fruit and scopoletin comparator (Exrtasynthese, 
France) with n-hexane: ethyl acetate (1.5 : 3.5) as the eluent showed the same Rf value of 0.56 (Figure. 1).  
 
 
 
Figure 1:  Thin-layer chromatograms of scopoletin under the UV light 365 nm (1. Scopoletin isolated from noni fruit; 
2. Scopoletin comparator) 
 
The examination of the ultraviolet (UV) spectrum of the isolated scopoletin showed the same 
spectrum as compared to scopoletin comparator. Both spectra huddled together as shown in Figure 2. The 
comparison of the results of the wavelength and absorbance values of the two compounds are shown in Table 
1.  
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Figure 2: UV Spectrum of scopoletin isolated from noni fruit and scopoletin comparator 
 
Table 1: Wavelength (λ) and the absorbance peak of scopoletin 
 
 
 
 
 
 
 
 
 
The experiment started by sensitizing mice with ovalbumin 5 mg/20 g intraperitoneally. This route of 
administration was used to introduce the antigen to the immune system more quickly as the peritoneal cavity 
has many macrophage cells (MHC class II). Thus, the animals were expected to become sensitive to the antigen 
more rapidly. The next antigen exposure was given on the third day in the same dose subcutaneously where 
the type I hypersensitivity reaction did not appear. The type I hypersensitivity reactions appeared after the 
administration of ovalbumin subcutaneously on the seventh day characterized by redness around the site of 
injection. The redness is caused by the interaction between the ovalbumin antigen with IgE on the surface of 
mastocyte and basophil cells. When the second exposure of the same antigen happens, one molecule of the 
antigen binds two adjacent IgE molecules on the Fab fragment. This leads to enzymatic activity in the cell 
membrane and subsequently the release of chemical mediators stored in granules in the mast cells and 
basophil cells such as histamine, bradykinin, prostaglandins, leukotrienes and others. These mediators are 
responsible for the onset of type I hypersensitivity reaction. The histamines collectively increase capillary 
permeability and lead to vasodilatation of blood vessels in the skin of mice and caused the redness arise. 
 
The level of IL-4 in type I hypersensitive mice following administration of antigen subcutaneously 
increased 388.17% after 24 hours as compared to normal group. This suggests that antigen exposure after the 
animals experienced type I hypersensitivity reaction increases the production of IL-4 cytokine which is 
responsible for type I hypersensitivity reactions. 
 
Scopoletin was given at the doses of 1, 3, and 10 mg/kg orally to type I hypersensitive mice. After 1 
day (24 hours) of administration, animals were sacrificed by guillotine, serum was separated and then the 
concentration of IL-4 was determined by ELISA method. 
 
In the determination of IL-4 level, the standard curve was made by using the IL-4 standard at a 
wavelength of 450 nm. Regression equation of IL-4 standard was Y = 0.011 X with R
2
 = 0.952.  
 
No 
Peak wavelength (nm) Absorbance 
Scopoletin isolated 
from noni fruit 
Scopoletin 
Comparator 
Scopoletin isolated 
from noni fruit 
Scopoletin 
Comparator 
1 345.50 345.2 0.411 0.481 
2 297.0 296.0 0.151 0.237 
3 253.0 254.0 0.119 0.271 
4 228.4 228.6 0.423 0.671 
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Figure 3: IR spectrum of scopoletin isolated from noni fruit 
 
Table 2: Wavenumber (cm
-1
) and functional groups of scopoletin 
 
No 
Wavenumber (cm
-1
) 
Functional Group 
Scopoletin isolated from noni fruit Scopoletin comparator 
1 3327 (3700-3100) 3339 (3700-3100) Hidroxy 
2 1707 (1900-1650) 1703 (1900-1650) Ketones (carbonyl) 
3 1605, 1569, 1514 (1600-1450) 1608, 1567, 1510 (1600-1450) C=C 
3 1605, 1569, 1514 (1600-1450) 1608, 1567, 1510 (1600-1450) C=C 
4 1447, 1408, 1394, (1465-1350) 1447, 1435 (1465-1350) C-H 
5 1220, 1197, 1168, 1144, 1112, 
1023, 985 (1250-1000) 
1220, 1190, 1161, 1141, 1100, 
1019 (1250-1000) 
C-O 
6 864, 853, 813, 746, 719 (900-700) 862, 841, 821, 746, 714 Substituted sugar 
 
The serum level of IL-4 in type I hypersensitive mice is presented in Table 3 and the comparison of 
serum levels of IL-4 among the groups of type I hypersensitive mice with various doses of scopoletin is 
presented in Figure 5. Scopoletin at the doses of 1, 3 and 10 mg/kg could decrease the serum level of IL-4 in 
type I hypersensitive mice significantly (p <0.01). Decreased levels of IL-4 in type I hypersensitive mice causes a 
direct impact to Tho cells and plasma cells and decreases the production of IgE. Bonferroni test (Figure 4) 
revealed that the reduction of IL-4 levels by scopoletin at the doses of 1 and 3 mg/kg showed insignificant 
difference (p> 0.05), while the doses of 3 and 10 mg/kg showed significant difference (p <0.05). Scopoletin at 
the dose of 10 mg/kg decreased the IL-4 level of type I hypersensitive mice to the normal level (p> 0.05). 
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Figure 4: IR spectrum of scopoletin comparator 
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Figure 5: Relationship between doses of scopoletin isolated from noni fruit and serum levels of IL-4 in type I 
hypersensitive mice. 
 
Table 3: Serum levels of IL-4 in the type I hypersensitive mice after administration of scopoletin isolated from noni 
fruit. 
 
Treatment Group 
Serum levels of IL-4 (pg/ml) 
Averages (pg/ml) 
1 2 3 4 5 
I. Normal animals 47.27 34.73 28.36 35.27 28.55 34.84 ± 7.69 
II. Control 139.64 156.18 123.45 146.91 110.00 135.24 ± 18.51 
III. Scopoletin 1 mg/kg 84.91 86.91 86.18 76.73 89.64 84.87 ± 4.87 
IV. Scopoletin 3 mg/kg 82.73 64.18 83.64 64.73 50.73 69.20 ± 13.95 
V. Scopoletin 10 mg/kg 46.18 52.73 62.36 48.36 63.45 54.62 ± 7.93 
 
 The major function of IL-4 is in the regulation of the immune response mediated by IgE and mastocyte 
or eusinophil cells. The activity of IL-4 is not limited on B cells only, but also on T cells, macrophages, 
granulocytes, mastocytes, erythrocyte precursors and megakaryocytes. IL-4 acts as a stimulator of Th2 cells 
and inhibits the activity of macrophages, but this effect can be countered by the INF [6, 21].Increased level of 
IL-4 in animals experiencing type I hypersensitivity reactions will affect the activity of CD4 T cells to undergo 
cell proliferation and differentiation toward Th2 cells and subsequently increase the production of IL-4. 
Furthermore, IL-4 has receptors on the plasma cells that will be activated to produce IgE. Thus, decreased level 
of IL-4 will also lead to decreased production of IgE [6, 22]. 
 
CONCLUSIONS 
 
From the present study, we conclude that the administration of scopoletin at a doses of 1, 3, and 10 
mg/kg can decrease serum levels of IL-4 type I hypersensitive mice (p <0.01). Scopoletin at the dose of 10 
mg/kg can decrease the serum level of IL-4 in type I hypersensitive mice to the normal level (p> 0.05). 
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